Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Investors Guide
Investors Guide
Page 17 of 19
Finance
Pfizer-Allergan could be a super inversion deal
By
Stephen Gandel
October 29, 2015
Finance
First Data’s post-IPO earnings disappoint, but it’s well on the road to recovery
By
Shawn Tully
October 28, 2015
Finance
Valeant accounting scandal: 4 critical questions that have been left unanswered
By
Stephen Gandel
October 26, 2015
Finance
What the drop in Valeant’s stock says about hedge funds’ herd mentality
By
Stephen Gandel
October 25, 2015
Finance
Valeant’s accounting problems: It gets worse
By
Stephen Gandel
October 22, 2015
Finance
Forget the plunging stock price, here’s Valeant’s biggest problem
By
Laura Lorenzetti
October 22, 2015
Finance
Warren Buffett’s really bad week
By
Stephen Gandel
October 22, 2015
Finance
Are markets scared of a U.S. default?
By
Chris Matthews
October 20, 2015
Finance
It’s now the IP-No market
By
Stephen Gandel
October 20, 2015
Finance
Black Monday anniversary has not turned out to be all that worrisome for stocks
By
Stephen Gandel
October 19, 2015
Finance
The strange thing about Bill Ackman’s defense of Valeant’s drug prices
By
Stephen Gandel
October 7, 2015
International
Pacific trade negotiators reach landmark deal, fight over approval looms
By
Reuters
October 5, 2015
Finance
Here’s how the growing corporate debt bubble could burst
By
Stephen Gandel
October 4, 2015
Finance
Global commodity price slump sends ripples around the world
By
Reuters
October 3, 2015
Finance
No, October is often a great month for stocks
By
Stephen Gandel
October 1, 2015
Most Popular
Retail
Trump just declared December 26th a national holiday. What's open and closed?
By
Dave Smith
Success
As millions of Gen Zers face unemployment, CEOs of Amazon, Walmart, and McDonald's say opportunity is still there—if...
By
Preston Fore
Real Estate
Mark Zuckerberg gifted noise-canceling headphones to his Palo Alto neighbors because of the nonstop construction around...
By
Dave Smith